Journal History
| 1994 | The inaugural issue was released by Mutlimed Inc. Current Oncology was published as a quarterly journal. |
| 2005 | Journal website and peer review system was launched through Open Journal Systems. |
| 2006 | Current Oncology adopted a bimonthly publication schedule. |
| 2008 | Current Oncology was indexed in PubMed and archived in PubMed Central. Current Oncology was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics). |
| 2011 | Current Oncology received its first Impact Factor of 1.820. |
| 2018 | Current Oncology was indexed in MEDLINE—National Library of Medicine. |
| 2020 | Current Oncology received an updated Journal Impact Factor of 2.257. Current Oncology was published by MDPI from Volume 28, Issue 1 (2021). The Canadian Association of Psychosocial Oncology (CAPO) became affiliated to Current Oncology. |
| 2021 | Current Oncology established the following sections:
The Canadian Association of Medical Oncologists (CAMO), the Canadian Association of General Practitioners in Oncology (CAGPO) and the Cell Therapy Transplant Canada (CTTC) became affiliated to Current Oncology. |
| 2022 | Current Oncology established the following sections:
|
| 2023 | Current Oncology received its 2022 Impact Factor (2.6). |
| 2024 | The Canadian Centre for Applied Research in Cancer Control (ARCC) became affiliated to Current Oncology. |
Editor-in-Chief
| 2019–2023 | Editor-in-Chief: Prof. Dr. Sharlene Gill |
| 2023–present | Editor-in-Chief: Prof. Dr. Shahid Ahmed |
Section Editor-in-Chief
| 2021–2023 | Section Editor-in-Chief: Dr. Michael T. Halpern for the section on Health Economics |
| 2021–present | Section Editor-in-Chief: Dr. Stephen Yip for the section on Neuro-Oncology Section Editor-in-Chief: Dr. Normand Blais for the section on Thoracic Oncology Section Editor-in-Chief: Dr. Fiona Schulte for the section on Psychosocial Oncology Section Editor-in-Chief: Prof. Dr. Jörg Kleeff for the section on Surgical Oncology Section Editor-in-Chief: Dr. David Allan for the section on Cell Therapy |
| 2022–present | Section Editor-in-Chief: Prof. Dr. Tommaso Martino De Pas for the section on Bone and Soft Tissue Oncology Section Editor-in-Chief: Prof. Dr. Vittorio Gebbia for the section on Medical Oncology Section Editor-in-Chief: Dr. Pierre Yves Marcy for the section on Head and Neck Oncology Section Editor-in-Chief: Prof. Dr. Gavin Stuart for the section on Gynecologic Oncology Section Editor-in-Chief: Prof. Dr. Karen A. Gelmon for the section on Breast Cancer Section Editor-in-Chief: Prof. Dr. Margaret Fitch for the section on Oncology Nursing |
| 2023–present | Section Editor-in-Chief: Prof. Dr. Sharlene Gill for the section on Gastrointestinal Oncology |
| 2024–present | Section Editor-in-Chief: Prof. Dr. Matthias May for the section on Genitourinary Oncology Section Editor-in-Chief: Prof. Dr. Katrin Scheinemann for the section on Childhood, Adolescent and Young Adult Oncology Section Editor-in-Chief: Prof. Dr. Stuart Peacock for the section on Health Economics |
